Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder affecting 1
in 1,000 people and responsible for 10% of cases of the end stage renal disease (ESRD) …

: Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of end stage
renal disease and accounts for a substantial number of dialysis and transplant patients …

Background Polycystic kidney disease (PKD) accounts for approximately 15% of kidney
transplants, but long-term outcomes in patients with PKD who have received a kidney …

Background and objectives: For patients with end-stage renal disease (ESRD), the best
replacement therapy is renal transplant (RTx) to ensure life with good quality. Autosomal …

Abstract NIETO-RIOS, John Fredy et al. Clinical outcomes of kidney transplants on patients
with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and …

Kidney transplantation is indicated for end-stage renal disease. Autosomal dominant
polycystic kidney disease (ADPKD) causes structural degeneration of the kidney and …

Background This study investigated whether nature of primary renal disease affects clinical
outcomes after renal transplantation at a single center in the United Kingdom. Methods This …

Materials and Methods: Detailed data of patients with autosomal dominant polycystic kidney
disease were collected from medical records from the Shiraz Organ Transplantation Center …

Аутосомно-доминантная поликистозная болезнь почек-это распространенное
заболевание почек, поражающее все расовые группы во всем мире, занимающее одно …

Autosomal dominant polycystic kidney disease (ADPKD) affects approximately 1 in 1,000
people in the general population. The natural history of ADPKD includes the progression of …